Regal Assets Analytics

Repro-Med Systems (REPR) – Focus On Home Care Market Could Lead To Substantial Payoff Or Buyout

By |2015-01-15T14:35:08-05:00October 7th, 2014|Tags: , , , , , , , , , , , , , , , , |

Summary REPR’s flagship product has a firm grip on the growing infusion homecare market and REPR’s stock is trading at [...]

GeoTeam News 7/15/2014 >> ESYS,OPTT, YGE, SWRL, MEA, HIIQ, FTDL, GTT

By |2014-09-19T12:14:45-04:00July 15th, 2014|Tags: , , , , , , , , , , , , , , , |

Call(s) to Action: ESYS ($12.11, up > 13% in early trading) handily beats analyst EPS estimates by 62% with EPS [...]

Aegerion Pharmaceuticals (AEGR) Viability Threatened As Regulatory, Legal And Market Forces Close In

By |2014-09-19T13:39:39-04:00March 28th, 2014|Tags: , , , , , , , , , , , , , , , , , , , |

It's not often that evidence gathered in one of our investigations into a company that is not a classic pump [...]

GeoInvesting Responds To Bronte Capital On AmTrust

By |2014-09-19T13:39:55-04:00December 16th, 2013|Tags: , , , , , , , , , , , , , , , , , |

After our initial report on AmTrust Capital (AFSI), "Amtrust Financial Servies: A House of Cards?", Bronte Capital ("Bronte") criticized the [...]

Concrete Evidence That FAB Universal Issued Chinese Bonds Without Telling U.S. Investors

By |2014-09-19T13:39:56-04:00November 21st, 2013|Tags: , , , , , , , , , , , , , , , , , |

FAB Universal (FU) has completely failed to address in any substantive way a growing series of reports that challenge the [...]

Go to Top